Defence Therapeutics (XCNQ:DTC) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Defence Therapeutics's Free Cash Flow for the three months ended in Dec. 2023 was C$-1.39 Mil. Defence Therapeutics's Revenue for the three months ended in Dec. 2023 was C$0.00 Mil. Therefore, Defence Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Defence Therapeutics's current FCF Yield % is -8.50%.

The historical rank and industry rank for Defence Therapeutics's FCF Margin % or its related term are showing as below:

XCNQ:DTC's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -144.01
* Ranked among companies with meaningful FCF Margin % only.

Defence Therapeutics FCF Margin % Historical Data

The historical data trend for Defence Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics FCF Margin % Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

FCF Margin %

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Defence Therapeutics's FCF Margin %

For the Biotechnology subindustry, Defence Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Defence Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's FCF Margin % falls into.

Defence Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Defence Therapeutics's FCF Margin for the fiscal year that ended in Jun. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2022 )	/	Revenue (A: Jun. 2022 )
	=	-6.044	/	0
	=	%

Defence Therapeutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.394	/	0
	=	%

Defence Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director